Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

JOURNAL ARTICLE

Encouraging generic use can yield significant savings

Christina Zimmerman

Findings Brief: Health Care Financing & Organization 2012, 15 (8): 1-3

Key findings. (1) Zero copayment for generic drugs is the greatest influencer of generic statin utilization. (2) Both higher copayments for generic drugs and lower copayments for competing brands are associated with a decreased probability of using generic statins. (3) Prior authorization and step therapy requirements for brand-name statins are associated with an increased use of generic drugs. (4) Greater use of generic statins should reduce costs for patients, plans, and Medicare.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

In Medicare Part D plans, low or zero copays and other features to encourage the use of generic statins work, could save billions. John F Hoadley, Katie Merrell, Elizabeth Hargrave, Laura Summer Health Affairs 2012, 31 (10): 2266-75

Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit. Rajul A Patel, Mark P Walberg, Emily Tong, Florence Tan, Ashley E Rummel, Joseph A Woelfel, Sian M Carr-Lopez, Suzanne M Galal Journal of Managed Care & Specialty Pharmacy 2014, 20 (3): 283-90

Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Amber M Goedken, Julie M Urmie, Karen B Farris, William R Doucette Research in Social & Administrative Pharmacy: RSAP 2010, 6 (2): 100-9

Zero copayment for generic statins could save billions. (no author information available yet) Managed Care 2013, 22 (3): 44

Impact of final short-fill rule on Medicare Part D costs and long-term care pharmacy dispensing. Gary Bazalo, Richard C Weiss Consultant Pharmacist: the Journal of the American Society of Consultant Pharmacists 2012, 27 (4): 269-73

Generic script share and the price of brand-name drugs: the role of consumer choice. John A Rizzo, Richard Zeckhauser International Journal of Health Care Finance and Economics 2009, 9 (3): 291-316

Impact of medicare part D plan features on use of generic drugs. Yan Tang, Walid F Gellad, Aiju Men, Julie M Donohue Medical Care 2014, 52 (6): 541-8

Private expenditures on brand name prescription drugs after generic entry. Dahlia Y Balaban, Irfan A Dhalla, Michael R Law, Chaim M Bell Applied Health Economics and Health Policy 2013, 11 (5): 523-9

A comparison of costs of Medicare Part D prescriptions dispensed at retail and mail order pharmacies. Norman V Carroll Journal of Managed Care & Specialty Pharmacy 2014, 20 (9): 959-67

Comparison of prescription drug costs in the United States and the United Kingdom, Part 1: statins. Hershel Jick, Andrew Wilson, Peter Wiggins, Douglas P Chamberlin Pharmacotherapy 2012, 32 (1): 1-6

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Encouraging generic use can yield significant savings

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips